Microvisk Technologies has raised £6m in a third successful funding round, bringing the total that the company has secured to £10.5m over the past 12 months.
Microvisk has created the world’s first medical diagnostic strip based on a micro-electro-mechanical system. The company originally devised the technology as a movement system for nano-robots at Rutherford Appleton Laboratories in Oxfordshire.
Microvisk is now using the sensor technology in a tiny strip to monitor the blood-clotting status of patients taking the drug Warfarin.
The SmartStrip is a disposable strip that uses embedded sensors to work out the clotting speed of blood from a finger-prick sample and the results are displayed on a handheld reader. The device is robust enough to be used by patients at home or in the doctor’s surgery.
Microvisk is gearing up to launch its Smartstrip device onto the UK market this autumn. The company is using the new capital to continue clinical trials in the UK and expand its research and manufacturing facilities.
It is also preparing to commence trials in the US and Germany within the next six months, with product launches in both countries anticipated to follow in 2012.
Engineers have developed a cheaper and more convenient solution to measure the effectiveness of blood clotting. Click here to read more.